Soren Mogelsvang – Peak BioPharma

Soren Mogelsvang

soren2Dr. Mogelsvang is dynamic biotech executive and entrepreneur with over 15 years of experience in translational research, antibody development and ISO compliant manufacturing, Dr. Mogelsvang has a proven track record in product and IP development, laboratory and operations management.

He is currently the President and CEO of Peak BioPharma Corporation which is leading the development and extraction of natural, plant-based cannabinoids. He was recently the VP of Research and Development at Serpin Pharma, and  was formerly VP of R&D at Caerus Discovery, Head of Cell Biology at ATCC and Director of Laboratory and Production at Affinity BioReagents.

With over a dozen biomedical patent applications, he is a former instructor, faculty member and postdoctoral fellow at the University Of Colorado School Of Medicine, holding a PhD in Biochemistry (Cambridge, UK), and an MSc in Plant Molecular Biology (University of Copenhagen).